Cargando…
Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2
Novel coronavirus disease 2019 (COVID-19) causes pulmonary and cardiovascular disorders and has become a worldwide emergency. Myocardial injury can be caused by direct or indirect damage, particularly mediated by a cytokine storm, a disordered immune response that can cause myocarditis, abnormal coa...
Autores principales: | dos Anjos, Fernanda, Simões, Júlia Leão Batista, Assmann, Charles Elias, Carvalho, Fabiano Barbosa, Bagatini, Margarete Dulce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709498/ https://www.ncbi.nlm.nih.gov/pubmed/33299899 http://dx.doi.org/10.1155/2020/8632048 |
Ejemplares similares
-
Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue
por: Leão Batista Simões, Júlia, et al.
Publicado: (2021) -
Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome
por: Simões, Júlia Leão Batista, et al.
Publicado: (2021) -
Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection
por: Simões, Júlia Leão Batista, et al.
Publicado: (2021) -
Editorial: Purinergic signaling and neuroinflammation
por: Assmann, Charles Elias, et al.
Publicado: (2022) -
Therapeutic Potential of the Purinergic System in Major Depressive Disorder Associated with COVID-19
por: Simões, Júlia Leão Batista, et al.
Publicado: (2022)